Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Posts Tagged ‘Deerfield Management’

Covalis Capital's Returns, AUM and Holdings

Hedge Fund and Insider Trading News: Ray Dalio, Nelson Peltz, Weight Watchers International, Inc. (WTW), Xeris Pharmaceuticals Inc (XERS), Carolina Financial Corporation (CARO), and More

‘Pain + Reflection = Progress’: Here are 13 Brilliant Quotes from Hedge-fund Legend Ray Dalio (Business Insider) Hedge fund legend Ray Dalio, who......(read more)
Countries with the Smallest Government Per Capita in the WorldCountries with the Smallest Government Per Capita in the World

Hedge Fund and Insider Trading News: Eddie Lampert, Elliott Management, Limelight Networks, Inc. (LLNW), The New York Times Company (NYT), Spectrum Pharmaceuticals, Inc. (SPPI), and More

Eddie Lampert is Seeking to Sell Sears Assets to his Hedge Fund – This will be Bad for Sears (Verdict.co.uk) In wanting to sell Sears’ assets......(read more)
Peter Kolchinsky

Five Stocks To Buy According To Top Biotech-Focused Funds

Biotechnology is a very interesting industry to invest in, but also very complex. If you are looking for stocks that are most likely to see their value......(read more)
Countries With Highest Medical Research Spending

13G Filing: James E. Flynn and Natera Inc. (NTRA)

Natera Inc. (NASDAQ:NTRA): James E. Flynn’s Deerfield Management filed an amended 13D. You can check out Deerfield Management’s latest holdings......(read more)
Pressmaster/Shutterstock.com

13D Filing: James E. Flynn and AveXis Inc (AVXS)

AveXis Inc (NASDAQ:AVXS): James E. Flynn’s Deerfield Management filed an amended 13D. You can check out Deerfield Management’s latest holdings......(read more)
James Flynn Deerfield Management

13D Filing: James E. Flynn and Adeptus Health Inc. (ADPT)

You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 8 – SEC Filing SECURITIES AND EXCHANGE COMMISSION Washington......(read more)
James Flynn Deerfield Management

13G Filing: James E. Flynn and Mannkind Corp (MNKD)

You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 13 – SEC Filing   SECURITIES AND EXCHANGE COMMISSION......(read more)
Bill Ackman, Pershing Square Capital Management, Herbalife

Hedge Fund News: Bill Ackman, Deerfield Management, Elliott Management

Bill Ackman Is Moving His Office To Hell’s Kitchen (CNBC) It’s official: Hedge fund titan Bill Ackman is moving Pershing Square Capital to......(read more)
James Flynn Deerfield Management

Vanda Pharmaceuticals Inc. (VNDA) Stock: Deerfield Management Cashes In 2.56 Million Shares

According to a freshly-amended 13G filing with the Securities and Exchange Commission, James E. Flynn‘s Deerfield Management has sold around......(read more)
James Flynn Deerfield Management

Catabasis Pharmaceuticals Inc (CATB): Deerfield Management Adds to Its Position

James E. Flynn‘s Deerfield Management recently filed a Form 13G with the SEC in which it reported holding 783,375 common shares of Catabasis Pharmaceuticals......(read more)
emergency, room, doctor, sick, group, latin, medical, profession, patient, doc, concept, life, middle, clinic, male, corridor, occupation, service, gurney, ill, worker, female,

Adeptus Health Inc. (ADPT): James E. Flynn’s Deerfield Management Monitoring Search for New CEO

James E. Flynn, manager of Deerfield Management, recently contacted Gregory W. Scott, a member of the Board of Adeptus Health Inc. (NYSE:ADPT) concerning......(read more)
pharmaceuticals-385956_1280

5 Stocks That Healthcare Fund Deerfield Management Was Buying in Q2

Founded by James E. Flynn in 2000, Deerfield Management has grown to become one of the premier healthcare-focused investment management companies today......(read more)
Abbvie ABBV biopharmaceuticals cell blood dna gene stem test biotech research

Deerfield Management Discloses Stake In Post-IPO Audentes Therapeutics (BOLD)

James E. Flynn and his fund, Deerfield Management, have disclosed a stake in Audentes Therapeutics Inc (NASDAQ:BOLD), a company that has recently closed......(read more)
James Flynn Deerfield Management

Portola Pharmaceuticals Inc (PTLA): This Hedge Fund is Loading Up Following Stock’s Weakness

It’s been a disastrous year for Portola Pharmaceuticals Inc (NASDAQ:PTLA) thus far, as the company has shed over 60% of its value year-to-date.......(read more)
James Flynn Deerfield Management

13D Filing: James Flynn’s Deerfield Management Takes 9.99% Stake in Newly-Public AveXis, Inc. (AVXS)

AveXis Inc (NASDAQ:AVXS) is the subject of a new 13D filing issued by James Flynn‘s Deerfield Management, which reveals a 2.24 million-share position......(read more)
Paul Singer ELLIOTT MANAGEMENT

Billionaire Singer Lifts Stake in Cabelas Inc. (CAB), Deerfield Bets on Beloranib, Plus Two Other Moves

Numerous closely-watched hedge fund vehicles are currently disclosing their equity positions as of the end of 2015, so individual investors can monitor......(read more)
James Flynn Deerfield Management

Billionaires James Flynn, David Abrams, Among the Elite Investors Buying These 4 Stocks Last Week

Individual investors might find hedge fund investing quite expensive, considering the 2-and-2o fee structure most hedge funds employ. However, mimicking......(read more)
Keith Meister, Corvex Capital

A Look At Smart Money Three Latest Moves

In new filings with the U.S. Securities and Exchange Commission, Kelly Cardwell’s Central Square Management, James E. Flynn’s Deerfield Management......(read more)
stocks, analysis, market, numbers, business, ticker, trade, money, price, investment, index, chart

Smart Money Is Seeing Upside For These Three Companies

Three companies have recently been the subject of bullish moves by hedge funds. Let us take a look at what makes these companies seem undervalued to hedgies......(read more)
TIGER GLOBAL Investor Letter

Tiger Global Cuts Stake in Autohome, While Deerfield Buys More Shares of This Pharmaceutical Company

Federal funds future contracts suggest a 79% probability that the Federal Reserve will raise interest rates at the December policy meeting, an event which......(read more)
HIGHBRIDGE CAPITAL MANAGEMENT

Elite Hedge Funds Make Big Moves In These 3 Healthcare Stocks

A Schedule 13G is a public filing that must be submitted with the SEC by every hedge fund manager or other investor who acquires ownership of more than......(read more)
James Flynn Deerfield Management

Elite Hedge Funds Believe These Two Stocks Are Golden Opportunities

There are not many signals at the moment that suggest a continuation of the so-called “correction”, except for the potential letdown of the current......(read more)
10 Pharmacist Shortage Countries in Need of Pharmacists in 2017

Three Healthcare Stocks Hedge Funds Are Snapping Up

Is it a good time to buy Alimera Sciences Inc (NASDAQ:ALIM)? James E. Flynn thinks so, having recently acquired 321,784 shares of the pharmaceutical......(read more)
James Flynn Deerfield Management

Sequenom, Aclaris, and Xenoport Making Waves Among Elite Healthcare Investors

Three prominent healthcare-focused funds that we track at Insider Monkey submitted filings with the SEC today, disclosing new or bulked up positions in......(read more)
James Flynn Deerfield Management

Hedge Funds’ Make Moves On Newly-Public Biotech And “Undervalued” Broker

The U.S equities markets have seriously pulled back lately, so hedge funds and other investors are stumbling upon a greater number of quality investing......(read more)
James Flynn Deerfield Management

Two Stocks That Have Deerfield Management And Anchor Bolt Capital Excited

In a recent filing with the Securities and Exchange Commission (SEC), James E. Flynn (pictured) has revealed his latest play: Akari Therapeutics PLC (......(read more)
James Flynn Deerfield Management

Deerfield Management Discloses 3.66% Stake In Newly Public Company Global Blood Therapeutics Inc. (GBT)

James E. Flynn’s Deerfield Management has filed a Schedule 13G disclosing a 3.66% ownership stake in the newly public company Global Blood Therapeutics......(read more)
James Flynn Deerfield Management

Deerfield Management Buys More And More Imprivata Inc. (IMPR) Shares

James E. Flynn’s Deerfield Management has filed a 13G with the U.S. Securities and Exchange Commission regarding its ownership of shares of Imprivata......(read more)
James Flynn Deerfield Management

James Flynn’s Deerfield Management Ups Its Stake In Neos Therapeutics Inc. (NEOS)

James E. Flynn’s Deerfield Management disclosed that it has upped its position in Neos Therapeutics Inc. (NASDAQ:NEOS) by 545,833 shares since the fund......(read more)
Neos Therapeutics

Deerfield Management Discloses Stake In Recently Public Neos Therapeutics Inc (NEOS)

Constantly on the hunt for biotechnology stocks, James E. Flynn has identified another potential winner. In a recent Form 3 filing with the Securities......(read more)
healthcare

Deerfield Management Ups Passive Stake In Streamline Health Solutions Inc. (STRM) To 12.18%

Deerfield Management, led by James E. Flynn, has increased its stake in Streamline Health Solutions Inc. (NASDAQ:STRM). In a newly-amended 13G filing......(read more)
active-84646_1280

Does James Flynn Think the Entry Point For Healthways, Inc. (HWAY) Has Arrived, And Should You Enter?

According to a recent filing with the Securities and Exchange Commission, James E. Flynn‘s Deerfield Management has acquired about 2.47 million......(read more)
CITADEL INVESTMENT GROUP

Ken Griffin And James Flynn Are Not Wasting Any Time Getting In On These New IPOs

Ken Griffin‘s (pictured) Citadel Investment Group has acquired about 1.09 million shares of 8Point3 Energy Partners LP (NASDAQ:CAFD). The holding......(read more)
Sergey Nivens/shutterstock.com

Deerfield Management Bets Big On Company It Polished Ahead Of IPO, Nivalis Therapeutics Inc (NVLS)

Following the initial public offering of Nivalis Therapeutics Inc (NASDAQ:NVLS) today, James E. Flynn‘s Deerfield Management, which was a stakeholder......(read more)
NUMAX3D/shutterstock.com

Deerfield Management Trims Holding In Antares Pharma Inc (ATRS) Just Before Disastrous Setback

According to a recent filing with the Securities and Exchange Commission, James E. Flynn‘s Deerfield Management has trimmed its stake in Antares......(read more)
hxdbzxy/shutterstock.com

Deerfield Management’s Top Health Stocks ~ Auspex Pharmaceuticals Inc (ASPX), Horizon Pharma PLC (HZNP), AbbVie Inc (ABBV)

James Flynn‘s Deerfield Management has filed its 13F with the SEC for the reporting period of March 31, with the investment manager disclosing ......(read more)
Broadfin Kevin Kotler

Carbylan Therapeutics Inc (CBYL): Broadfin’s Latest Move and Market Smashing Q1 Returns Inside

To say Kevin Kotler’s Broadfin Capital had exceptional Q1 returns from its 11 long positions in companies valued at $1 billion or more would be a gross......(read more)
best paying jobs

Steadymed Ltd (STDY), Achillion Pharmaceuticals, Inc. (ACHN), & Nevro Corp (NVRO): James Flynn’s Latest Healthcare Picks

James E. Flynn of Deerfield Management, recently disclosed a stake of 1.27 million shares in Steadymed Ltd (NASDAQ:STDY). Of this stake, 737,555 shares......(read more)
10 best industries to invest in

Biotech Hedge Fund Deerfield Management’s Top Stock Picks

James E. Flynn‘s Deerfield Management is one of the funds that is focused on the healthcare sector, investing around 70% of its portfolio in healthcare......(read more)
Manning and Napier Inc (NYSE:MN)

Tonix Pharmaceuticals Holding Corp., Manning & Napier Inc: Deerfield, Ariel Open Bullish New Positions

James E. Flynn’s Deerfield Management entered a new position in Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) this week. According to the 13G Form......(read more)
Dmitry Balyasny

Funds Reveal New Positions in Peabody Energy Corporation (BTU), BIND Therapeutics Inc (BIND)

Two of our tracked funds have recently revealed in filings with the SEC that they’ve taken large new passive positions in a couple of stocks. Hal Mintz......(read more)
Axovant, AXON, Auspex Pharmaceuticals, Inc. (ASPX)

Auspex Pharmaceuticals Inc (ASPX): Deerfield Management Increase its Stake Following the Latest Public Offering of Stock

James E. Flynn’s Deerfield Management recently increased its stake in Auspex Pharmaceuticals Inc (NASDAQ:ASPX) by 1.5 million shares at $56.5 per share......(read more)
EHTH EHealth Inc logo

eHealth, Inc. (EHTH): Deerfield Management Picked a Bad Time to Buy 1 Million Shares of This Company

eHealth, Inc. (NASDAQ:EHTH) appears to have a major proponent in James E Flynn’s Deerfield Management, as the health-focused hedge fund continues......(read more)
Broadfin Kevin Kotler

Alcobra Ltd (ADHD): Broadfin Capital and Deerfield Initiate Passive Stakes Following Public Offering

Kevin Kotler’s Broadfin Capital and James Flynn’s Deerfield Management have both initiated passive stakes in Alcobra Ltd (NASDAQ:ADHD). As......(read more)
Vanda Pharmaceuticals Inc. (NASDAQ:VNDA)

Vanda Pharmaceuticals Inc (VNDA): Deerfield Management Increases Exposure Following Positive Announcement

James Flynn’s Deerfield Management disclosed an increase in its stake in Vanda Pharmaceuticals Inc (NASDAQ:VNDA) on Friday. After adding more than 1......(read more)
Peter Kolchinsky

Synergy Pharmaceuticals Inc (SGYP), Proteon Therapeutics Inc (PRTO): James E. Flynn and Peter Kolchinsky Think These Stocks Look Healthy

Synergy Pharmaceuticals Inc (NASDAQ:SGYP) and Proteon Therapeutics Inc (NASDAQ:PRTO) are in the spotlight as James E. Flynn’s Deerfield Management and......(read more)
Mario Gabelli

BioScrip Inc (BIOS), Proteon Therapeutics Inc (PRTO): GAMCO Investors and Deerfield Management Are Bullish on These Companies

Mario Gabelli’s GAMCO Investors and James E. Flynn’s Deerfield Management seem bullish on BioScrip Inc (NASDAQ:BIOS) and Proteon Therapeutics Inc (......(read more)
Proteon-therapeutics-logo

Proteon Therapeutics Inc (PRTO): Deerfield Management Discloses Post-IPO 6.7% Stake

James E. Flynn’s Deerfield Management filed yesterday with the SEC an Initial Statement of Beneficial Ownership of Securities of Proteon Therapeutics......(read more)
Alimera Sciences Inc (NASDAQ:ALIM)

Alimera Sciences Inc (ALIM) & Bio Blast Pharma Ltd (ORPN): 2 Pharmaceutical Stocks Hedge Funds are Increasing Their Stakes In

Pharmaceuticals and life sciences as a sector is where most of the money from hedge funds seems to be flowing in. However, it’s the sector-specific......(read more)
Entegris Inc (NASDAQ:ENTG)

Entegris Inc (ENTG), Dicerna Pharmaceuticals Inc (DRNA): GMT Capital and Deerfield Management Report Their Latest Moves

In two new filings, Thomas E. Claugus‘ GMT Capital disclosed further raising its exposure to Entegris Inc (NASDAQ:ENTG). The investor revealed buying......(read more)